Abstract:
• In cats in which one middle cerebral artery was occluded, cortical blood flow (CBF) was measured and the superficial cortical microvasculature was observed bilaterally before and after the intravenous injection of a vasoactive drug. Aminophylline produced decreased CBF in the nonischemic cerebral hemispheres of five of seven animals and arterial constriction in three. Ergotamine tartrate produced arterial constriction in the nonischemic hemispheres of four animals and decreased CBF in three. Neither drug consistently produced increased CBF in ischemic cerebral tissue. Acetazolamide caused vasodilatation in the nonischemic hemispheres of seven animals and increased CBF in five. Increased CBF was not due entirely to changes of Pa<x) 2 . CBF also increased in ischemic hemispheres of four of the seven animals given acetazolamide.
ADDITIONAL KEY WORDS
acid-base relationships krypton-85 CO2 transport migraine treatment carbonic anhydrase Paco 2 response extracellular pH regulation of cerebral circulation H + and HCO a~ transport vasoconstricting drugs
• Substances that normally dilate cerebral blood vessels, such as carbon dioxide and papaverine, may have no effect or a deleterious effect on the circulation of blood in brain tissue that is ischemic or otherwise damaged. 1 " 6 Therefore, it has been suggested that constriction of arterial blood vessels in nonischemic brain tissue, produced by a drug or a decrease of Pa C o 2 during hyperventilation, might lead to an increase of blood flow in ischemic brain tissue. 4 " 8 Such an increase of flow could occur from a decrease of cerebral vascular resistance caused by a decrease of intracranial pressure or from a redirection of flow caused by impaired reactivity and failure of regulatory arterioles in ischemic brain tissue to constrict.
1 " 5 -° Present evidence for the effectiveness of hyperventilation in decreasing the sizes of cerebral infarcts in humans and animals is inconclusive, 10 "
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influence ischemic changes in the cerebral microvasculature.
in In the present study, aminophylline and ergotamine tartrate, two drugs thought to be vasoconstrictors, 8 ' 18~"31 and acetazolamide, an inhibitor of carbonic anhydrase that can increase cerebral blood flow, 82 " 39 were used in an experimental model of acute cerebral ischemia. Measurement of cortical blood flow (CBF) and observations of the superficial cortical microvasculature were made before and after the intraveous administration of the drugs to cats in which one middle cerebral artery (MCA) had been occluded, to allow comparisons of the effects on both ischemic and nonischemic brain tissue.
Methods
Fifteen adult cats were used for the study. The surgical, experimental, and analytical procedures have been described in detail.
1 '
40 Each cat was anesthetized with halothane, and a tracheal stoma was made. Catheters were placed (1) in the abdominal aorta through a femoral artery, (2) in the inferior vena cava through a femoral vein, and (3) in the brachiocephalic artery through the right subclavian artery. The right MCA was occluded by an extradural approach. Wide, bilateral craniectomies were made, and the exposed surfaces of the brain were protected with thin s'.:eets of plastic film. Mean systemic arterial blood pressure (MABP) and cardiac (pulse) rate were recorded via a strain-gauge transducer attached to the catheter in the abdominal aorta, and arterial P COo , pH, P 02 , and hematocrit values were measured from blood obtained from this catheter. Rectal temperature was monitored with a thermistor and kept between 37 and 38 C with a water blanket controlled by the thermistor. After completion of the surgical procedures, the concentration of halothane in the inspired air was decreased to 0.3 to 0.5%, minimal amounts of dtubocurarine chloride were given for respiratory paralysis, and the cat was ventilated mechanically with a respirator.
CBF was measured from both cerebral hemispheres simultaneously by kinetic analysis of the curves of appearance and clearance of the beta activity of krypton-85 injected into the brachiocephalic artery. The superficial cortical microvasculature was observed through an operation microscope, and macrophotographs were made bilaterally for measurements of the calibers of arteries 50 to 250 microns in diameter. In each cat, two to three measurements of CBF and arterial caliber were made after the completion of the surgical procedures and before the injection of vasoactive drugs.
The drugs were dissolved in physiological saline and injected, over a period of eight to 18 minutes, into the catheter in the vena cava: aminophylline to seven cats in doses ranging from 3.7 to 7.3 mg/kg; ergotamine tartrate to four cats in doses ranging from 0.052 to 0.180 mg/kg; and acetazolamide to seven cats in doses ranging from 27 to 41 mg/kg (three of these cats had received aminophylline earlier).
Repeated measurements of CBF and arterial caliber were made for varying periods after the injections of the drugs. The variability of the method used for the measurement of CBF can account for differences of CBF values of up to 14% 2 ; differences between values obtained before and after the injection of a drug that were greater than 14% were considered meaningful and indicative of an effect of the drug on the cerebral circulation. Although the method requires continuous recording of beta activity from the brain for at least ten minutes after the injection of krypton-85, most of the information is contained in the first few minutes of the curve of clearance of the indicator* 1 ; thus, the times of measurement of CBF were taken as the times of the injections of krypton-85, related to the times of completion of the injections of the drugs.
The cats given acetazolamide were passively hyperventilated after the effects of the drug had become established to decrease Pa COo to baseline values. The Pa COo was increased in these and all other cats at the end of the experiments by increasing the amount of carbon dioxide in the ventilating mixture, and the reactivity of the cerebral vasculature of the nonischemic hemispheres was verified by additional measurements of CBF and cortical arterial caliber. The data reported here are only from cats that had appropriate responses of the vasculature of the nonischemic hemispheres.
Results

AMINOPHYLLINE
Nineteen measurements of CBF were made from the nonischemic cerebral hemispheres after injection (table 1). Changes of Paco 2 , when they occurred, were slight. MABP increased appreciably in two cats and decreased late after the injection in one.
Although slight constriction of superficial cortical arteries was noted in the nonischemic hemisphere in only three of the seven cats, meaningful decreases of CBF occurred at some time after the injection in five cats. The mean of the CBF values obtained from 17 to 32 •C = constriction; NC = no change.
•f+ -appropriate response; 0 = no response; P = paradoxical response. Meaningful difference from measurement before injection. §P < 0.05 for difference from mean before injection. o\ §Meaningful difference from measurement before injection.
ui
\\P < 0.05 for difference from mean before injection.
minutes after the injection of aminophylline was lower than the mean of the values obtained before injection (P<0.05). In cat 3, a transient increase of CBF was noted immediately after the injection, for no apparent cause.
Aminophylline did not cause a change of caliber of the superficial arteries of the ischemic cortex in any of the seven cats. An increase of CBF occurred after injection in cats 2 and 4; in cat 4, the increase of CBF was associated with an increase of MABP, and there was an area of regional hyperemia 
ERGOTAMINE TARTRATE
Twelve measurements of CBF were made from the nonischemic hemispheres after injection (table 2) . Cardiac (pulse) rate decreased in each of the four cats. Changes of MABP were variable, but in each cat the superficial cortical arteries constricted. This constriction was accompanied by decreases of CBF in the nonischemic hemispheres of three cats; one of these (cat 11) had an associated decrease of Pa C02 .
Arterial constriction occurred in the ischemic hemisphere of one cat. There was a decrease of CBF in this cat 36 minutes after the injection, but there was a decrease of MABP as well. Decreases of CBF also occurred in the ischemic hemispheres of two cats that had decreases in the nonischemic hemispheres. CBF values for the ischemic hemispheres of these four cats generally were less than those for the cats given aminophylline or acetazolamide.
Two of the four cats had appropriate responses of CBF of ischemic tissue to increases of Pa C o,; one of the four had appropriate arterial dilatation.
ACETAZOLAMIDE
Twenty-four measurements of CBF were made from the nonischemic hemispheres after injec-466 tion; included were seven measurements made during passive hyperventilation (table 3) . Increases of Pa C o 2 occurred after injection in each of the seven cats; Paco 2 was decreased to near the preinjection values by hyperventilation. MABP increased in two cats and decreased in two.
The means of the CBF values obtained from the nonischemic hemispheres after injection of acetazolamide were significantly greater than the mean of values before injection, but the subsequent hyperventilation caused decreases of CBF, so that the mean of these values was not significantly different from the beforeinjection mean. Increases of CBF occurred in the nonischemic hemispheres of five of the seven cats. With hyperventilation the increases of CBF persisted in three cats but at a somewhat lesser value. Dilatation of surface arteries was observed in each of the cats, although the change of caliber was slight in two.
No changes of arterial caliber were noted in the ischemic hemispheres. However, increases of CBF occurred in the ischemic hemispheres of three cats. In addition, with hyperventilation there was an increase of CBF in cat 5.
There was no change of arterial caliber in the ischemic hemisphere of any of the seven cats when Paco., was increased. Paradoxical reactions of CBF to increases of Paco 2 occurred in three cats, including two of those that had increases of CBF during hyperventilation after injection of acetazolamide.
Discussion
VASOCONSTRICTING DRUGS
The effectiveness of ergotamine tartrate for the treatment of acute migraine has been ascribed to its ability to cause constriction of extracerebral blood vessels. Studies of cerebral vessels have provided conflicting results, 16 " 20 ' -2 related in part to differences of mode of administration and dosage. The present study demonstrates clearly that the intravenous injection of ergotamine tartrate, in moderate as well as large doses, causes constriction of cerebral arteries. Despite vasoconstriction, decreases of CBF do not always occur. The apparent dissociation between arterial caliber and CBF is explained by the technique used for observation of surface vessels: those that are smaller than 50 microns in diameter, including 
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the arterioles that presumably regulate CBF, cannot be resolved adequately by the macrophotographic technique. The vasoconstricting effects of ergotamine tartrate on arterioles may be minimal, so that CBF is not decreased. Nevertheless, the findings support the adage that ergot derivatives should not be used for the treatment of migraine in patients with cardiovascular (or cerebrovascular) disease.
Studies of the cervical blood vessels have shown increases of blood flow to the head after the administration of theophylline derivatives, 18 Aminophylline has been suggested for the treatment of cerebral ischemia, and, as with hyperventilation, early results in humans have been inconclusive but interpreted as showing some beneficial effect. 8 In the present study, increases of CBF occurred in ischemic brain tissue in only two of seven cats given aminophylline, and one of these had an increase of MABP associated with reddening of venous blood, suggesting regional reactive hyperemia.
9 ' 41 - 42 The decreases of CBF and arterial constriction seen in the ischemic hemispheres could have been due to progressive ischemia 1 rather than to effects of the drugs. Although the influences of changes of intracranial pressure could not be determined in this study, it appears unlikely that vasoconstricting drugs will prove to be effective for the treatment of cerebral ischemia.
ACETAZOLAMIDE
Increases of cerebral blood flow after the administration of acetazolamide have been described. 82 Acetazolamide caused increases of CBF of the ischemic hemisphere in at least three and possibly four of the seven cats in this study. Such an effect has not been found for any of the other drugs tested with this model of experimental acute cerebral ischemia.
1 --It is unlikely that the slight increases of Pa C o.. produced by acetazolamide were responsible for the increases of CBF in ischemic brain tissue.
2 -5 ' 7 ' 14 As in nonischemic brain tissue, the increases of CBF produced by acetazolamide were independent of changes of Pa co .,, at least in part: in three cats (no. 5, 14, and 15), CBF of the ischemic cerebral hemisphere was increased during hyperventilation, and two of these cats had paradoxical reactions to increases of Pa C o 2 later in the experiment.
No ready explanation is apparent for the increases of CBF of ischemic brain tissue that occur with acetazolamide. Although changes of extracellular fluid pH may be responsible in part, differential dilatation of collateral arterial channels, dilatation of larger arterial vessels at the base of the brain, in the neck, or in the rete mirabile (of animals that have such a structure), or generalized large-vessel dilatation with associated increases of cardiac output also could account for the findings. These are only speculations at present.
The effects of acetazolamide on CBF of ischemic brain tissue may be dependent on craniectomy. If the skull were not open, increases of intracranial pressure from vasodilatation in nonischemic brain tissue might produce increases of cerebral vascular resistance that would decrease or prevent increases of CBF in ischemic brain tissue. Results of preliminary investigations of the use of acetazolaraide for the treatment of patients with strokes are conflicting. 80 ' 51 Because of the present study, an investigation of the effects of acetazolamide on regional cerebral blood flow and the sizes of cerebral infarcts after MCA occlusion is under way in animals with intact skulls. 
